Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr-Jun;4(2):85-91.
doi: 10.4103/2303-9027.156711.

Endoscopic ultrasound-guided liver biopsy

Parth J Parekh  1 , Raj Majithia  2 , David L Diehl  3 , Todd H Baron  4
Affiliations
Review

Endoscopic ultrasound-guided liver biopsy

Parth J Parekh et al. Endosc Ultrasound. 2015 Apr-Jun.

Abstract

Liver biopsy remains the cornerstone in the diagnosis and management of liver disorders. Results of liver biopsy can often drive therapeutic decision-making. Unfortunately, studies have shown conventional biopsy techniques to carry significant sampling variability that can potentially impact patient care. Endoscopic ultrasound (EUS) is gaining traction as an alternative method of biopsy. For parenchymal disease, it can decrease sampling variability. It offers a more targeted approach for focal lesions. Its diagnostic yield and limited adverse event profile make it a promising approach for liver biopsy.

Keywords: EUS-guided liver biopsy (EUS-LB); Endoscopic ultrasound (EUS); Tru-Cut biopsy; fine needle biopsy; liver biopsy; nonalcoholic fatty liver disease (NAFLD); nonalcoholic steatohepatitis (NASH).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol. 2001;35:195–9. - PubMed
    1. Sorbi D, Mcgill DB, Thistle JL, et al. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. Am J Gastroenterol. 2000;95:3206–10. - PubMed
    1. Gor N, Salem SB, Jakate S, et al. Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non-Tru-Cut FNA needle. Gastrointest Endosc. 2014;79:170–2. - PubMed
    1. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–8. - PubMed
    1. Denzer U, Arnoldy A, Kanzler S, et al. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: Diagnosis of cirrhosis and complications. J Clin Gastroenterol. 2007;41:103–10. - PubMed